Navigation Links
ERT Unveils Full Range of ePRO Solutions Providing the Power of Choice for Clinical Trial Sponsors
Date:12/16/2010

PHILADELPHIA, Dec. 16, 2010 /PRNewswire/ -- ERT (Nasdaq: ERES), a global provider of technology and services to the pharmaceutical, biotechnology and medical device industries, today announced the launch of its comprehensive suite of electronic patient-reported outcome (ePRO) solutions. As the ePRO market continues to grow, ePRO tools have increasingly become more sophisticated, with their development reflecting the diverse needs of sponsors and facilitating compliance by the patient. ERT now offers a broad range of proven modalities of technology, offering the ability to choose the best ePRO solution to suit the requirements of the trial, ensuring its accuracy and success.

The selection of the ideal ePRO modality is reliant on multiple factors including questionnaire complexity, length, site location, patient population, budget and size of trial. To facilitate this complex selection criteria, ERT offers a diverse range of complementary ePRO tools accepted by regulatory authorities globally for collection of reliable accurate data. ERT solutions include the VIAPhone®, VIAPad®, VIAPen® and VIAWeb®, all of which offer the advantages of simplicity, mobility and immediacy of use over traditional paper based methods.  

ERT's VIAPad solution has the capacity for complex diaries, questionnaires and visual scales, alongside the ability to streamline mid-study changes. The VIAWeb solution enables all patients to use a standard internet browser at home or work to securely log into their study diary or assessment and complete necessary information. This is ideal for patients busy at work, with little time to visit a clinical trial site. The VIAPen is a digital pen that offers the simplicity of paper-based methods with the dual advantage of digital data collection. Completing the suite of solutions offered is the VIAPhone, otherwise known as an Interactiv
'/>"/>

SOURCE ERT
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. CO-REC Unveils List of Approved Electronic Health Record Products
2. Siemens Unveils Biograph mMR Whole-Body Integrated MR-PET System Capable of Simultaneous Data Acquisition
3. Forte Research Systems Unveils the Allegro™ Research on Demand Cloud-Based Product Line
4. Panasonic Unveils CardioHealth® Station at American Heart Association 2010
5. Panasonic Unveils CardioHealth® Station - First Comprehensive Screening Solution to Detect Heart Disease in Asymptomatic Population
6. Biopharma Company UCB Unveils 40 Deserving 2010 Family Epilepsy Scholarship Recipients
7. Shrink Nanotechnologies Unveils Videos of StemDisc450 Prototype Growing Human Embryonic Stem Cells
8. Cleveland Clinic Unveils Top 10 Medical Innovations for 2011
9. Thomson Reuters Unveils Pharmacy Xpert Solution to Improve Medication Management for Hospital Pharmacists
10. Express Scripts Unveils New Opportunities to Drive Down Healthcare Costs; Presents Five Studies at Academy of Managed Care Pharmacy Conference
11. Inc. Magazine Unveils 29th Annual List of Americas Fastest-Growing Private Companies—the Inc. 500
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... ANN ARBOR, Mich. , Sept. 18, 2014 /PRNewswire-USNewswire/ ... Medical Research will allow the University of Michigan to ... The Glenn Center for Aging Research ... growing evidence that drugs can slow the effects of ... to unlock mechanisms of aging that can help develop ...
(Date:9/18/2014)... , Sept. 18, 2014   3D Systems   ... the Simbionix RobotiX Mentor™ , a new robotic surgery ... the first time at the ERUS exhibition in ... (booth #7). Robotic-assisted minimally invasive surgery represents a ... means the needs for training for robotic surgery has increased, ...
(Date:9/18/2014)... , Sept. 18, 2014  Halozyme Therapeutics, Inc. ... the U.S. Food and Drug Administration (FDA) has ... dosing of PEGPH20 in SWOG,s ongoing Phase 1b/2 ... evaluate Halozyme,s investigational drug PEGPH20 (PEGylated Recombinant Human ... in patients with metastatic pancreatic adenocarcinoma.  The study ...
Breaking Medicine Technology:$3 M grant funds Paul F. Glenn Center for Aging Research at the University of Michigan 2$3 M grant funds Paul F. Glenn Center for Aging Research at the University of Michigan 33D Systems Introduces New Simbionix Robotics Training Platform 23D Systems Introduces New Simbionix Robotics Training Platform 3SWOG To Resume Clinical Trial Of Halozyme's PEGPH20 In Combination With Modified FOLFIRINOX For Advanced Pancreatic Cancer 2SWOG To Resume Clinical Trial Of Halozyme's PEGPH20 In Combination With Modified FOLFIRINOX For Advanced Pancreatic Cancer 3SWOG To Resume Clinical Trial Of Halozyme's PEGPH20 In Combination With Modified FOLFIRINOX For Advanced Pancreatic Cancer 4
... YORK, Dec. 13, 2010 The board of directors of ... 20-cent first-quarter 2011 dividend on the company,s common stock, payable ... of business on February 4, 2011.  Pfizer increased the dividend ... per share. (Logo: http://photos.prnewswire.com/prnh/20100416/PFIZERLOGO) "This dividend ...
... BERNARDINO, Calif., Dec. 13, 2010 Out ... nation, IEHP Medicare DualChoice (HMO SNP) is one of only five ... Part D quality and performance from the Centers for Medicare and ... to gauge how well health and drug plans perform on a ...
Cached Medicine Technology:Pfizer Declares A 20-Cent First-Quarter 2011 Dividend 2IEHP Earns Highest Rating for Medicare Part D Quality and Performance 2
(Date:9/18/2014)... York, New York (PRWEB) September 18, 2014 ... Xarelto lawsuits ( http://www.xareltolawsuitcenter.com ) currently pending in ... to have all claims filed on behalf of ... to motions filed on September 11th, the defendants ... other claims contained in the lawsuits have no ...
(Date:9/18/2014)... Memorial Cardiac and Vascular Institute ... performing the first ever, adult heart transplant in Broward ... Sharing) approval to launch the adult heart transplant program ... in South Florida. , The skilled cardiac transplant ... Medical Director of the Adult Heart Transplant and Mechanical ...
(Date:9/18/2014)... 18, 2014 (HealthDay News) -- Older people become more ... because the balance of stress hormones during bereavement changes ... people who are grieving are more likely to have ... "During the difficult weeks and months after loss, ... the most abundant type of white blood cell and ...
(Date:9/18/2014)... (PRWEB) September 18, 2014 One of ... air medical transport industry, ShandsCair Flight Program’s ... Helicopters Inc . (AHI) at the Air Medical Transport ... recently delivered and placed into service ShandsCair EC155 and ... will be displayed at AMTC highlight Airbus Helicopters broad, ...
(Date:9/18/2014)... (HealthDay News) -- Daily supplements of selenium or vitamin ... of age-related cataracts among men, a new study indicates. ... both could help prevent cataracts. To investigate this further, ... Medical School in Boston, and his colleagues examined data ... E. The trial was initially designed to study prevention ...
Breaking Medicine News(10 mins):Health News:Xarelto Lawsuit Defendants Seek to Have Pennsylvania Claims Filed by Out-of-State Plaintiffs Dismissed, Bernstein Liebhard LLP Reports 2Health News:Xarelto Lawsuit Defendants Seek to Have Pennsylvania Claims Filed by Out-of-State Plaintiffs Dismissed, Bernstein Liebhard LLP Reports 3Health News:Memorial Cardiac & Vascular Institute Performs First Adult Heart Transplant in Broward County 2Health News:Memorial Cardiac & Vascular Institute Performs First Adult Heart Transplant in Broward County 3Health News:Memorial Cardiac & Vascular Institute Performs First Adult Heart Transplant in Broward County 4Health News:Grief Can Weigh on Immune System in Older Folks, Study Says 2Health News:Airbus Helicopters Inc. Features Industry-leading Models at AMTC 2Health News:Airbus Helicopters Inc. Features Industry-leading Models at AMTC 3Health News:Airbus Helicopters Inc. Features Industry-leading Models at AMTC 4Health News:Vitamin E, Selenium Supplements Don't Seem to Prevent Cataracts 2
... new study researchers say they found that chest pain ... elderly patients treated // with angioplasty and those on ... these benefits earlier. ,Patients treated with surgery ... treated patients required more antianginal drugs throughout the study. ...
... most common symptom in patients with plaque build-up in ... medication // nifedipine (Adalat or Procardia) may be safe ... angina symptoms and prolongs heart-problem-and-procedure-free survival. ,For ... nifedipine gastrointestinal therapeutic system or a placebo. GITS modifies ...
... solvents and cleaning products at home may increase the ... findings from a recent study. Researchers found the levels ... the homes of children with asthma. Volatile organic compounds ... polishes, room fresheners, fitted carpets, and cigarette smoke. ...
... Researchers from the University of Florida College of Medicine ... for hypertension // in older patients. Researchers say most ... blood pressure, so this study was set up to ... study found patients had similar outcomes when they took ...
... frustrated when patients ask them what type of bed is ... done// on this issue to support their answers. Therefore, researchers ... a firm vs. a medium-firm mattress when it comes to ... had their own bed mattresses replaced with either a firm ...
... degenerative joint disease and one of the oldest and ... joint’s cartilage breaks down and the bones rub against ... ,An international, multi-center study shows an effective treatment for ... Prexige. The drug was found to reduces gastric complications ...
Cached Medicine News:
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: